Glanbia delivers ‘strong performance’ in first half
Optimum Nutrition delivered double digit volume growth in the period 'driven by accelerating category growth'
7 August 2026
Glanbia has reported a strong performance in the first half of the year, its latest financial results show.
According to the six month period ended 4 July 2026, the group delivered volume and like-for-like revenue growth across all three segments, ‘reflecting disciplined execution as it continus to navigate whey cost inflation within Performance Nutrition’.
Optimum Nutrition delivered double digit volume growth in the period, the report shows, driven by accelerating category growth, increased distribution, ongoing innovation and the brand’s continued leadership within the category.
‘Strong volume growth’
The group noted that it generated strong volume growth across Health & Nutrition (H&N) and Dairy Nutrition (DN), with good demand in H&N’s end-use markets and strong volume and pricing growth in protein solutions within DN.
We generated strong cash flow, increased our interim dividend by 10% and returned €100 million to shareholders via our share buyback programme, the company added.
In a statement, Hugh McGuire, CEO, Glanbia, said: “We continue to advance our group-wide transformation programme, and following strong progress year-to-date, we are now increasing our annual cost savings target from $60 million to $70 million [approx. €53 million to €62 million] by FY [full year] 2027.”
“As a protein powerhouse at the heart of better nutrition, Glanbia is uniquely positioned to meet the growing demand for nutrition that supports healthier and more active lives.
“We now expect adjusted EPS [earnings per share] growth of 17% to 20% which will be driven by category and end-use consumer market demand and a strong operating performance across all three segments.”
2026 outlook
Glanbia saw strong momentum in the first half of the year across all three segments, and while the group continues to closely monitor the geopolitical environment, based on current expectations for the remainder of the year, the group ‘now expects full year, 2026 adjusted EPS growth to be in the range of 17% to 20% constant currency (previously upper end of 7% to 11%)’.
Read more: Glanbia delivers ‘robust performance in 2025’
© 2026 by ShelfLife reporter



Print




Followers 0
Fans 0
Followers